State of Alaska Department of Revenue’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $564K | Sell |
7,534
-146
| -2% | -$9.38K | 0.01% | 1355 |
|
|
2026
Q1 | $431K | Hold |
7,680
| – | – | ﹤0.01% | 1472 |
|
|
2025
Q4 | $614K | Sell |
7,680
-461
| -6% | -$31K | 0.01% | 1350 |
|
|
2025
Q3 | $395K | Buy |
8,141
+2,496
| +44% | +$154K | ﹤0.01% | 1471 |
|
|
2025
Q2 | $421K | Sell |
5,645
-135
| -2% | -$8.94K | ﹤0.01% | 1433 |
|
|
2025
Q1 | $367K | Buy |
5,780
+50
| +0.9% | +$3.4K | ﹤0.01% | 1460 |
|
|
2024
Q4 | $447K | Sell |
5,730
-150
| -3% | -$12K | 0.01% | 1426 |
|
|
2024
Q3 | $472K | Buy |
5,880
+400
| +7% | +$32.3K | 0.01% | 1428 |
|
|
2024
Q2 | $453K | Hold |
5,480
| – | – | 0.01% | 1403 |
|
|
2024
Q1 | $467K | Hold |
5,480
| – | – | 0.01% | 1398 |
|
|
2023
Q4 | $468K | Sell |
5,480
-580
| -10% | -$50.1K | 0.01% | 1398 |
|
|
2023
Q3 | $542K | Sell |
6,060
-195
| -3% | -$17.4K | 0.01% | 1281 |
|
|
2023
Q2 | $532K | Sell |
6,255
-697
| -10% | -$58.9K | 0.01% | 1318 |
|
|
2023
Q1 | $575K | Sell |
6,952
-171
| -2% | -$13.8K | 0.01% | 1296 |
|
|
2022
Q4 | $560K | Hold |
7,123
| – | – | 0.01% | 1299 |
|
|
2022
Q3 | $527K | Sell |
7,123
-220
| -3% | -$15.8K | 0.01% | 1284 |
|
|
2022
Q2 | $478K | Buy |
7,343
+45
| +0.6% | +$2.66K | 0.01% | 1375 |
|
|
2022
Q1 | $461K | Sell |
7,298
-100
| -1% | -$5.44K | ﹤0.01% | 1423 |
|
|
2021
Q4 | $392K | Sell |
7,398
-650
| -8% | -$39.6K | ﹤0.01% | 1537 |
|
|
2021
Q3 | $568K | Buy |
8,048
+135
| +2% | +$8.52K | 0.01% | 1398 |
|
|
2021
Q2 | $527K | Sell |
7,913
-50
| -0.6% | -$3.54K | 0.01% | 1423 |
|
|
2021
Q1 | $883K | Sell |
7,963
-288
| -3% | -$35.6K | 0.01% | 1127 |
|
|
2020
Q4 | $979K | Sell |
8,251
-404
| -5% | -$43.5K | 0.01% | 986 |
|
|
2020
Q3 | $755K | Sell |
8,655
-305
| -3% | -$26.7K | 0.01% | 1021 |
|
|
2020
Q2 | $802K | Buy |
8,960
+227
| +3% | +$22.9K | 0.01% | 990 |
|
|
2020
Q1 | $870K | Buy |
8,733
+399
| +5% | +$43.3K | 0.01% | 828 |
|
|
2019
Q4 | $957K | Sell |
8,334
-694
| -8% | -$84K | 0.01% | 931 |
|
|
2019
Q3 | $1.14M | Buy |
+9,028
| New | +$1.15M | 0.02% | 790 |
|
|
2018
Q4 | – | Sell |
-3,800
| Closed | -$435K | – | 1667 |
|
|
2018
Q3 | $435K | Buy |
+3,800
| New | +$393K | 0.01% | 1189 |
|
|
2018
Q2 | – | Sell |
-17,248
| Closed | -$1.26M | – | 1647 |
|
|
2018
Q1 | $1.26M | Buy |
17,248
+6,720
| +64% | +$461K | 0.03% | 621 |
|
|
2017
Q4 | $611K | Buy |
10,528
+110
| +1% | +$5.79K | 0.01% | 728 |
|
|
2017
Q3 | $467K | Buy |
10,418
+60
| +0.6% | +$2.49K | 0.02% | 713 |
|
|
2017
Q2 | $409K | Buy |
10,358
+4,618
| +80% | +$190K | 0.03% | 504 |
|
|
2017
Q1 | $232K | Buy |
5,740
+130
| +2% | +$5.08K | 0.02% | 603 |
|
|
2016
Q4 | $225K | Buy |
+5,610
| New | +$212K | 0.02% | 399 |
|
Other funds holding HAE
AI
State of Alaska Department of Revenue's HAE Position: Q2 2026 in Review
State of Alaska Department of Revenue reduced its Haemonetics (HAE) stake by 1.9% in Q2 2026, selling an estimated $9.38K and leaving 7,534 shares worth $564K. The position accounts for 0.01% of the portfolio, ranked #1355.
State of Alaska Department of Revenue first reported a position in HAE in Q4 2016 and has held it in 35 quarters since. The position peaked at $1.26M in Q1 2018. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- State of Alaska Department of Revenue held 7,534 shares of Haemonetics worth $564K as of Q2 2026.
- State of Alaska Department of Revenue sold 146 Haemonetics shares in Q2 2026, an estimated $9.38K.
- Haemonetics made up 0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1355 holding.
- State of Alaska Department of Revenue first reported a position in Haemonetics in Q4 2016 and has held it in 35 quarters since.
- State of Alaska Department of Revenue's Haemonetics position peaked at $1.26M in Q1 2018.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.